Day: February 8, 2020

Adverum Biotechnologies Reports New Interim Data from Cohorts 1 and 2 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at Angiogenesis, Exudation, and Degeneration 2020

Written by Customer Service on . Posted in Public Companies.

— Robust efficacy with evidence of a dose response —— 6/6 patients rescue-injection-free in cohort 1, with 3 patients at 52 weeks — — 4/6 patients rescue-injection-free in cohort 2 (lower dose) at 24 weeks —— Company to host and webcast a discussion with key opinion leaders Sunday, February 9, at 10:00 am EST —REDWOOD CITY, Calif., Feb. 08, 2020 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced new interim clinical data from the OPTIC Phase 1 dose-ranging clinical trial of ADVM-022 intravitreal injection gene therapy. OPTIC includes treatment-experienced patients with wet age-related macular degeneration (AMD). The data are being presented today...

Continue reading

Nidec Announces Outlines of Planned Stock Split, Amendment to Articles of Incorporation, and Modification to Share Repurchase Program

Written by Customer Service on . Posted in Public Companies.

KYOTO, Japan, Feb. 08, 2020 (GLOBE NEWSWIRE) — Nidec Corporation (TSE: 6594; OTC US: NJDCY) (the “Company”) today announced that the Board of Directors of the Company, at a meeting held on February 8, 2020, made the following decisions regarding a stock split and an amendment to the Company’s Articles of Incorporation, as well as a modification to the Company’s share repurchase program resolved on January 23, 2020.1. Purposes of the Stock SplitThe Company has decided to implement a stock split to enhance the liquidity of the Company’s common stock and expand its investor base by reducing the trading price per share of the Company’s common stock.2. Outline of the Stock Split3. Amendment to the Article of Incorporation 4. Modification to the Share Purchase Program (Reference)Details...

Continue reading

Mitek Appoints Aaron Korsen as Vice President, North American Identity Sales

Written by Customer Service on . Posted in Public Companies.

SAN DIEGO, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Mitek Systems, Inc. (NASDAQ: MITK, www.miteksystems.com), a global leader in mobile capture and digital identity verification solutions, announced today that Aaron Korsen has been named Senior Vice President, North American Identity Sales.Most recently, Aaron led the North America sales operation for the Netsuite services.  Prior to Netsuite, Aaron led global sales for Kenandy, a SalesForce Ventures and Lightspeed-backed ERP software company. Before joining Kenandy, Aaron was Executive Vice President of Sales and Marketing at Luxent, a Salesforce.com service partner and application developer.  Korsen also spent 23 years at Epicor Software where he was the Senior Vice President of Sales and Marketing for its retail division (currently operating as Aptos) and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.